Lessons learned from the COVID pandemic and its impact on bioanalysis and drug development

The COVID-19 pandemic challenged pharmaceutical and bioanalytical communities at large, in the development of vaccines and therapeutics as well as supporting ongoing drug development efforts. Existing processes were challenged to manage loss of staffing at facilities along with added workloads for C...

Descripción completa

Detalles Bibliográficos
Autores principales: Wickremsinhe, Enaksha R, Brockus, Catherine L, Murphy, Anthony T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Newlands Press Ltd 2021
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288281/
https://www.ncbi.nlm.nih.gov/pubmed/34275332
http://dx.doi.org/10.4155/bio-2021-0120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288281/
https://www.ncbi.nlm.nih.gov/pubmed/34275332
http://dx.doi.org/10.4155/bio-2021-0120

Ejemplares similares